Using control charts to understand community variation in COVID-19.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 03 08 2020
accepted: 26 02 2021
entrez: 30 4 2021
pubmed: 1 5 2021
medline: 11 5 2021
Statut: epublish

Résumé

Decision-makers need signals for action as the coronavirus disease 2019 (COVID-19) pandemic progresses. Our aim was to demonstrate a novel use of statistical process control to provide timely and interpretable displays of COVID-19 data that inform local mitigation and containment strategies. Healthcare and other industries use statistical process control to study variation and disaggregate data for purposes of understanding behavior of processes and systems and intervening on them. We developed control charts at the county and city/neighborhood level within one state (California) to illustrate their potential value for decision-makers. We found that COVID-19 rates vary by region and subregion, with periods of exponential and non-exponential growth and decline. Such disaggregation provides granularity that decision-makers can use to respond to the pandemic. The annotated time series presentation connects events and policies with observed data that may help mobilize and direct the actions of residents and other stakeholders. Policy-makers and communities require access to relevant, accurate data to respond to the evolving COVID-19 pandemic. Control charts could prove valuable given their potential ease of use and interpretability in real-time decision-making and for communication about the pandemic at a meaningful level for communities.

Identifiants

pubmed: 33930013
doi: 10.1371/journal.pone.0248500
pii: PONE-D-20-24209
pmc: PMC8087083
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0248500

Subventions

Organisme : NIMH NIH HHS
ID : T32 MH080634
Pays : United States
Organisme : NCATS NIH HHS
ID : TL1 TR001883
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000124
Pays : United States

Déclaration de conflit d'intérêts

API provided support in the form of salaries for author LP. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Healthc (Amst). 2015 Dec;3(4):231-4
pubmed: 26699349
JAMA. 2008 Mar 12;299(10):1182-4
pubmed: 18334694
JAMA. 2016 Apr 5;315(13):1329-30
pubmed: 26940610
Proc R Soc Med. 1965 May;58:295-300
pubmed: 14283879
Qual Saf Health Care. 2003 Dec;12(6):458-64
pubmed: 14645763
Int J Qual Health Care. 2021 Mar 5;33(1):
pubmed: 32589224
Infect Control Hosp Epidemiol. 1998 Apr;19(4):265-83
pubmed: 9605277
BMJ Qual Saf. 2011 Apr;20 Suppl 1:i36-40
pubmed: 21450768
Infect Control Hosp Epidemiol. 1998 Mar;19(3):194-214
pubmed: 9552190
Matern Child Health J. 2019 Jun;23(6):739-745
pubmed: 30627951
Am J Med Genet B Neuropsychiatr Genet. 2016 Sep;171(6):806-14
pubmed: 27004590
Qual Manag Health Care. 2013 Jul-Sep;22(3):170-86
pubmed: 23807130
J Public Health Manag Pract. 2016 Mar-Apr;22(2):E21-7
pubmed: 25325397

Auteurs

Moira Inkelas (M)

Department of Health Policy and Management, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States of America.
Population Health Program, Clinical and Translational Science Institute, University of California Los Angeles, Los Angeles, California, United States of America.

Cheríe Blair (C)

Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

Daisuke Furukawa (D)

Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

Vladimir G Manuel (VG)

Population Health Program, Clinical and Translational Science Institute, University of California Los Angeles, Los Angeles, California, United States of America.
Department of Family Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

Jason H Malenfant (JH)

Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

Emily Martin (E)

Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

Iheanacho Emeruwa (I)

Population Health Program, Clinical and Translational Science Institute, University of California Los Angeles, Los Angeles, California, United States of America.
Division of Critical Care Pulmonology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.

Tony Kuo (T)

Population Health Program, Clinical and Translational Science Institute, University of California Los Angeles, Los Angeles, California, United States of America.
Department of Family Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States of America.
Division of Chronic Disease and Injury Prevention, Los Angeles County Department of Public Health, Los Angeles, California, United States of America.

Lisa Arangua (L)

Division of Chronic Disease and Injury Prevention, Los Angeles County Department of Public Health, Los Angeles, California, United States of America.

Brenda Robles (B)

Division of Chronic Disease and Injury Prevention, Los Angeles County Department of Public Health, Los Angeles, California, United States of America.

Lloyd P Provost (LP)

Associates for Process Improvement, Austin, Texas, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH